Press release
GSK Launches Trelegy Ellipta The First Single-Inhaler Triple Therapy For COPD And Asthma Trend: A Crucial Influence on the Drug Device Combination Market's Transformation in 2025
Drug Device Combination Market Size
The rising incidence of long-term illnesses is predicted to propel the drug-device combination market's growth. Chronic ailments are characterized as those that last for over a year, disrupt day-to-day activities, require constant medical attention, or a combination of both. These ailments include heart disease, diabetes, among others. Drug-device combinations, which serve both therapeutic and diagnostic purposes, are instrumental in effectively treating individuals plagued by such chronic diseases. A study by the World Health Organization, a dedicated branch of the United Nations that ensures global public health, revealed that diabetes affected over 420 million people worldwide in 2022. By 2030 and 2045, these figures are projected to soar to 578 million and 700 million respectively. Consequently, this spike in chronic disease incidences is fuelling the expansion of the drug-device combination market.
Get Your Drug Device Combination Market Report Here:
https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report
How will the growth rate of the drug device combination market shape industry trends by 2034?
The increase in the drug device combination market recently has been quite dramatic, with the market expanding from $131.01 billion in 2024 to $145.29 billion in 2025, marking a compound annual growth rate (CAGR) of 10.9%. This significant growth during the historic period can be credited to factors like escalating medical innovation, prevalence of chronic diseases, a patient-orientated approach, progression in biologics, the complexities of monotherapy, and clinical necessities.
Fast-paced expansion is anticipated in the drug device combination market in the near future, with projections placing it at $227.94 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.9%. Such growth in this period can be credited to factors such as patient empowerment and engagement, the digitalization of healthcare, expansion of the global market, the advent of new therapies, and a focus on value-based healthcare. Dominant trends expected during this forecast period involve therapeutic advancements, management of complex diseases, patient-oriented care, tech innovation, and backing from regulatory bodies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8206&type=smp
What trends are poised to drive the future success of the drug device combination market?
Leading companies within the drug combination device market, such as GSK, are utilizing product innovation to maintain their market standing. A notable example of this is the Trelegy Ellipta, a novel inhaler that administers a specific medication dosage to the lungs. Introduced by the UK-based pharmaceutical and biotechnology company, GSK, in April 2022, the Trelegy Ellipta represents the first triple therapy delivered via a single inhaler. These devices are both compact and easily transportable. They are primarily utilized in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. The unique attribute of the Trelegy Ellipta is its ability to hold three distinct types of drugs in foil packaging, making it an effective drug combination device. The inhaler integrates three key active ingredients: fluticasone furoate, umeclidinium, and vilanterol. Therefore, the Trelegy Ellipta serves as a powerful drug combination device, optimizing patient management of respiratory conditions through its comprehensive delivery system.
Which primary segments of the drug device combination market are driving growth and industry transformations?
The drug device combination market covered in this report is segmented -
1) By Product: Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens, Other Products
2) By Distribution Channel: Direct Tender, Retails Sales, Other Distribution Channels
3) By Application: Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, Other Applications
4) By End User: Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers, Other End Users
Subsegments:
1) By Auto-Injector: Pre-Filled Auto-Injectors, Reusable Auto-Injectors
2) By Microneedle Patch: Dissolving Microneedle Patches, Coated Microneedle Patches
3) By Digital Pill: Ingestible Sensors, Smart Capsules
4) By Smart Inhaler: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)
5) By Drug Delivery Hydrogels: Injectable Hydrogels, Topical Hydrogels
6) By Drug-Eluting Lens: Contact Lenses, Intraocular Lenses
7) By Other Products: Transdermal Patches, Implantable Drug Delivery Systems
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8206
Which geographical regions are pioneering growth in the drug device combination market?
North America was the largest region in the drug-device combination market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug device combination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the drug device combination market landscape?
Major companies operating in the drug device combination market are The 3M Company, Abbott India Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Medtronic PLC, Ypsomed Holding AG, Micron Biomedical Inc., MetP Pharma AG, Sonceboz SA, Lepu Medical Technology (Beijing) Co. Ltd., Eitan Medical Ltd., Vaxess Technologies Inc., Subcuject Aps, Allergan PLC, Terumo Corporation, Stryker Corporation, Becton Dickinson and Company, Zimmer Biomet Holdings Inc., MediPrint Ophthalmics, Arrow International Inc., Alcon Inc., W. L. Gore & Associates Inc., Cook Medical LLC, Pinnacle Biologics Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8206&type=smp
What Is Covered In The Drug Device Combination Global Market Report?
• Market Size Forecast: Examine the drug device combination market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the drug device combination market for a structured understanding.
• Key Players Overview: Analyze major players in the drug device combination market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the drug device combination market.
• Segment Contributions: Evaluate how different segments drive overall growth in the drug device combination market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the drug device combination market.
• Industry Challenges: Identify potential risks and obstacles affecting the drug device combination market.
• Competitive Landscape: Review strategic developments in the drug device combination market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GSK Launches Trelegy Ellipta The First Single-Inhaler Triple Therapy For COPD And Asthma Trend: A Crucial Influence on the Drug Device Combination Market's Transformation in 2025 here
News-ID: 3887023 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Community Banking Market: 2025-2034 Forecast Repo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Community Banking Industry Market Size Be by 2025?
In recent times, the community banking sector has witnessed robust growth. The market size, which is projected to be $17.79 billion in 2024, is predicted to climb to $19.39 billion in 2025 with a compound annual growth rate…
2025 Commercial Property Management Market Outlook: Key Indicators Shaping Growt …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Commercial Property Management Industry Market Size Be by 2025?
In recent times, the market size of commercial property management has witnessed substantial expansion. It is projected to escalate from $385.63 billion in 2024 to an impressive $413.80 billion in 2025, accumulating a compound annual growth rate…
Top Trends Transforming the Commercial Grounds Maintenance Market Landscape in 2 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Commercial Grounds Maintenance Industry Market Size Be by 2025?
The size of the commercial grounds maintenance market has seen a robust growth in the past few years. The market, which was valued at $36.88 billion in 2024, is expected to climb to $39.20 billion in 2025,…
Coatings And Application Technologies For Robotics: Core Growth Enabler in the G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Coatings And Application Technologies For Robotics Industry Market Size Be by 2025?
In recent times, the market size for coatings and application technologies for robotics has seen a swift expansion. The market anticipates expanding from $20.47 billion in 2024 to $22.71 billion in 2025, with a…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
